Tags: Chemical Compound, Chemical Substance.

Minodronic acid is a third-generation bisphosphonate drug. It is approved for use in Japan for the treatment of osteoporosis. Its mechanism of action involves inhibition of farnesyl pyrophosphate synthase activity.

Minodronic_acid.svg
FDA UNII code
40SGR63TGL
IUPAC name
(1-Hydroxy-2-imidazo[12-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid

Loading...

This page contains content from the copyrighted Wikipedia article "Minodronic acid"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.